Ann: Change in substantial holding - Phillip Asset Management, page-6

WHY OH why do you persist with your uninformed ramblings, despite other posters have showed you the number of IPSC applications outstanding with the FDA who fully "have their head around" IPSC's and have indeed given clearance to a host of IPSC NDA applications (just a few more examples for you - yawn) including even gene edited IPSC treatments:

https://www.bayer.com/media/en-us/bluerock-therapeutics-announces-fda-clearance-of-ind-application-for-investigational-ipsc-derived-cell-therapy-opct-001-for-the-treatment-of-primary-photoreceptor-diseases/
https://www.biospace.com/press-releases/help-therapeutics-announces-fda-clearance-of-ind-application-for-universal-ipsc-derived-hicm-188-cell-therapy-for-the-treatment-of-end-stage-heart-failure
https://aml-hub.com/medical-information/fda-clears-ft538-the-first-crispr-edited-ipsc-derived-cell-therapy-for-investigation-as-a-new-drug-in-aml-and-mm
https://www.bioworld.com/articles/710616-fda-approves-ind-for-myopaxon-in-duchennes-muscular-dystrophy?v=preview
https://www.biospace.com/press-releases/rxcell-inc-granted-u-s-patent-for-ipsc-based-cell-therapy
https://parkinsonsnewstoday.com/news/fda-clears-clinical-trial-anpd001-stem-cell-therapy/
https://www.prnewswire.com/news-releases/bio-techne-announces-submission-of-fda-drug-master-file-for-excellerate-gmp-ipsc-expansion-medium-supporting-stem-cell-therapy-302019517.html

etc, etc, etc.

And indeed have had "their heads around them" long before CYP's clearance back in 2022:

https://www.biospace.com/us-fda-clears-ind-for-cynata-s-phase-2-clinical-trial-of-cyp-001-in-gvhd

You really need to stop projecting your own ignorance onto the FDA, in this New Year Gavsy' and understand they've approved, not just cleared for study, but approved, a swathe of advanced cellular therapies you are ignorant to (and indeed at last, the first 'truly' allogeneic stem cell therapy with MSB):

https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products

Even back in 2023 the FDA approved a genome editing treatment for use Gavsey, my dear boy. The FDA thankfully has a far better grasp on these new fangled innovative cell based therapies out there, than you Gavin. Your ignorant and persisted ten years projection is absolute horse hang.